Results

Total Results: 110 records

Showing results for "indication".
Users also searched for: medication reconciliation

21. AHRQ CEDAR introduction (pdf file)
    cds.ahrq.gov/cedar/AHRQ_CEDAR_Information_Sheet.pdf
    October 01, 2022 - AHRQ CEDAR introduction AHRQ CEDAR CEPI Evidence Discovery And Retrieval A Direct Line to AHRQ-Sponsored Information and Evidence CEDAR [The Agency For Healthcare Research and Quality’s (AHRQ) Center for Evidence and Practice Improvement (CEPI) Evidence Discovery and Retrieval] is an open-source project which …

22. PowerPoint Presentation
    cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
    January 01, 2012 - PowerPoint Presentation Decision Support to Improve Childhood Obesity Management Jeremy Michel, MD, MHS Physician-Informatician The Children’s Hospital of Philadelphia & ECRI Institute 1 Disclosures Work I will be discussing was indirectly funded by the American Beverage Foundation through an unrestricted grant t…

23. CDS Connect Work Group Meeting Summary 5-21-2020 (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/1176/CDS%20Connect%20Work%20Group%20May%202020%20Meeting%20Summary.pdf
    May 21, 2020 - CDS Connect Work Group Meeting Summary 5-21-2020 CDS (Clinical Decision Support) Connect Work Group Meeting Summary May 21, 2020 3:00 - 4:00 pm ET Attendees: 48 people including 3 phone dial-ins (51 total) Organization Attendee Names AHRQ Members Steve Bernstein, Roland Gamache ,Ed Lomotan, , Mario Terán (4…

24. April 2022 CDS Connect Work Group Summary (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/143366/CDS_Connect_WG_April_2022_Summary.pdf
    January 01, 2022 - April 2022 CDS Connect Work Group Summary Clinical Decision Support (CDS) Connect Work Group (WG) Meeting Summary April 21, 2022 3:00 – 4:00 pm ET Attendees: 31 people, including 6 phone dial-ins Organization Attendees AHRQ Sponsors Edwin Lomatan, Mario Teran, Roland Gamache (3) WG Members Alex Go…

25. CDS Connect Work Group June 2021 Summary (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdf
    January 01, 2021 - CDS Connect Work Group June 2021 Summary CDS (Clinical Decision Support) Connect Work Group Meeting Summary June 17, 2021 3:00-4:00 pm ET Attendees: 41 people, including 3 phone dial-ins Organization Attendee Names AHRQ Sponsors Edwin Lomotan; Mario Teran; Roland Gamache; Steve Bernstein (4) Work Group…

26. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - A result of >130 mg/dL is an indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of dyslipidemia, a risk factor for developing CAD and stroke.

27. Feb-2017-Cholesterol-Wg-Notes (doc file)
    cds.ahrq.gov/sites/default/files/workgroups/221/feb-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 02/08/2017 Time 1:30 – 3:30 PM ET AGENDA · Welcome · Discuss Remaining Repository Questions · Clarify 10-Year Risk Assessment Details · Discuss Statin Therapy for the Prevention and Treatment of CVD eCQM/CDS Artifact · Discuss Next Artifacts for Developmen…

28. Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdf
    January 01, 2024 - Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening Implementation Guide Prediabetes and Type 2 Diabetes: Part One, Screening Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Modern…

29. Implementation Guide: Healthy Diet and Physical Activity for Cardiovascular Disease Prevention in Adults with Cardiovascular Risk Factors (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1071/Implementation_Guide_Healthy_Diet_and_Physical_Activity.pdf
    September 01, 2022 - A result of > 130 mg/dL is an indication of dyslipidemia. … A result of < 40 mg/dL is an indication of dyslipidemia.

30. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
    September 01, 2022 - A result of >130 mg/dL is an indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of dyslipidemia, a risk factor for developing CAD and stroke.

31. Implementation Guide: Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2023 - A result of >130 mg/dL is an indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of dyslipidemia, a risk factor for developing CAD and stroke.

32. June 2021 CDS Connect Work Group Slides (pdf file)
    cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdf
    January 01, 2021 - June 2021 CDS Connect Work Group Slides June 2021 CDS Connect Work Group Call Meeting Agenda Schedule Topic 3:00 - 3:02 • Roll Call, Michelle Lenox (MITRE) 3:02 - 3:05 • Review of the Agenda, Maria Michaels (CDC) 3:05 - 3:50 • Using CDS to Reduce Harm From Drug-Drug Interactions: Case Study of Warfarin and N…

33. CDS Connect Implementation Guide Draft (doc file)
    cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
    October 01, 2017 - CDS Connect Implementation Guide Draft Agency for Healthcare Research and Quality (AHRQ) Agency for Healthcare Research and Quality (AHRQ) Error! No text of specified style in document. Implementation Guide Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk Prepared for: Agency for Healthcare Re…

34. Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary508_with%202020%20updates%202.pdf
    May 01, 2020 - Rationale Inclusion “Adjuvant analgesic medication” Non-opioid medications that have a primary indication … Medications that have a primary indication for a “non-pain” condition, but are occasionally used to

35. Implementation Guide: Factors to Consider in Managing Chronic Pain: A Pain Management Summary (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary50810012018.pdf
    December 01, 2018 - Inclusion “Adjuvant analgesic medication” Non-opioid medications that have a primary indication for … Medications that have a primary indication for a “non-pain” condition, but are occasionally used to

36. Statin Use for the Primary Prevention of CVD in Adults: Clinician-Facing CDS Intervention (April 2021) (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention_2.pdf
    April 01, 2021 - A result of >130 mg/dL is an indication of dyslipidemia, a risk factor for developing coronary artery … A result of <40 mg/dL is an indication of dyslipidemia, a risk factor for developing CAD and stroke.

37. Implementation Guide: Factors to Consider in Managing Chronic Pain (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary_1.pdf
    September 01, 2022 - Inclusion “Adjuvant analgesic medication” Nonopioid medications that have a primary indication for … Medications that have a primary indication for a “nonpain” condition, but are occasionally used to treat

38. Alcohol Screening Using the WHO AUDIT: Implementation Guide (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1166/WHO_Alcohol_Screening_IG_v2.pdf
    June 22, 2020 - The name of the test provides a general indication about the nature of what is being tested; in this

39. Alcohol Screening Using the WHO AUDIT: Implementation Guide (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1166/WHO_Alcohol_Screening_IG%20V3.pdf
    June 22, 2020 - The name of the test provides a general indication about the nature of what is being tested; in this

40. Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
    September 01, 2019 - Implementation Guide: Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening 1 Implementation Guide Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part One, Screening Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. HHSA290…